Abstract:Background: Sepsis is the overwhelming inflammatory response to infection, in which nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3 (NLRP3) inflammasome plays a crucial role. Shingosine-1-phosphate is reported to evoke NLRP3 inflammasome activation. Sphingosine kinase 1 (SphK1) is the major kinase that catalyzes bioactive lipid shingosine-1-phosphate formation and its role in sepsis remains uncertain. The authors hypothesize that SphK1 elicits NLRP3 inflammasome activation and exacerbates sepsis. Methods: Peripheral blood mononuclear cells were isolated from septic patients and healthy volunteers to measure messenger RNA (mRNA) expression. In mice, sepsis was induced by cecal ligation and puncture. Bone marrow-derived macrophages were prepared from C57BL/6J wild-type, Casp1(-/-), Nlrp3(-/-) and SphK1(-/-) mice. PF-543 was used as the specific inhibitor of SphK1. Mortality, peripheral perfusion, lung Evan's blue dye index, lung wet/dry ratio, lung injury score, lung myeloperoxidase activity, NLRP3 activation, and function of endothelial adherens junction were measured. Results:SphK1 mRNA expression was higher in cells from septic patients versus healthy volunteers (septic patients vs. healthy volunteers: 50.9 57.0 fold change vs. 1.2 +/- 0.1 fold change, P < 0.0001) and was positively correlated with IL-1<beta> mRNA expression in these cells (r = 0.537, P = 0.012) and negatively correlated with PaO2/Fio(2) ratios (r = 0.516, P = 0.017). In mice that had undergone cecal ligation and puncture, the 5-day mortality was 30% in PF-543-treated group and 80% in control group (n = 10 per group, P = 0.028). Compared with controls, PF-543-treated mice demonstrated improved peripheral perfusion and alleviated extravascular Evan's blue dye effusion (control vs. PF-543: 25.5 +/- 3.2ng/g vs. 18.2 +/- 1.4ng/g, P < 0.001), lower lung wet/dry ratio (control vs. PF-543: 8.0 <plus/minus> 0.2 vs. 7.1 +/- 0.4, P < 0.0001), descending lung injury score, and weaker lung myeloperoxidase activity. Inhibition of SphK1 suppressed caspase-1 maturation and interleukin-1<beta> release through repressing NLRP3 inflammasome activation, and subsequently stabilized vascular endothelial cadherin through suppressing interleukin-1 beta -evoked Src-mediated phosphorylation of vascular endothelial cadherin. Conclusions: SphK1 plays a crucial role in NLRP3 inflammasome activation and contributes to lung injury and mortality in mice polymicrobial sepsis.

Inhibition of cIAP1/2 reduces RIPK1 phosphorylation in pulmonary endothelial cells and alleviate sepsis-induced lung injury and inflammatory response

Inhibition of the C3a receptor attenuates sepsis-induced acute lung injury by suppressing pyroptosis of the pulmonary vascular endothelial cells

Group 2 innate lymphoid cells protect lung endothelial cells from pyroptosis in sepsis

Inhibition of sphingosine kinase 1 attenuates LPS-induced acute lung injury by suppressing endothelial cell pyroptosis

Protective Role of Ilc2 in Sepsis-Induced Acute Lung Injury

RIPK1 inhibitor ameliorates pulmonary injury by modulating the function of neutrophils and vascular endothelial cells

RIP1 kinase inactivation protects against LPS-induced acute respiratory distress syndrome in mice

C-176 inhibits macrophage polarization towards M1-subtype and ameliorates LPS induced acute kidney injury

SIRT1 Ameliorated Septic Associated-Lung Injury and Macrophages Apoptosis Via Inhibiting Endoplasmic Reticulum Stress.

Protective Effect of a Novel RIPK1 Inhibitor, Compound 4–155, in Systemic Inflammatory Response Syndrome and Sepsis

Apelin alleviates sepsis-induced acute lung injury in part by modulating the SIRT1/NLRP3 pathway to inhibit endothelial cell pyroptosis

SIRT1-Rab7 axis attenuates NLRP3 and STING activation through late endosomal-dependent mitophagy during sepsis-induced acute lung injury

Role of RIPK1 in the Pathogenesis of Acute Respiratory Distress Syndrome

RIPK1 in the inflammatory response and sepsis: Recent advances, drug discovery and beyond

Receptor-interacting protein 3 (RIP3) deficiency inhibits immune cell infiltration and attenuates organ injury in sepsis (INC6P.344)

EGFR-TNFR1 Pathway in Endothelial Cell Facilitates Acute Lung Injury by NF-κB/MAPK-mediated Inflammation and RIP3-dependent Necroptosis

CircC3P1 Attenuated Pro‐inflammatory Cytokine Production and Cell Apoptosis in Acute Lung Injury Induced by Sepsis Through Modulating Mir‐21

Loss of PADI2 and PADI4 ameliorates sepsis-induced acute lung injury by suppressing NLRP3+ macrophages

Crtc1 deficiency protects against sepsis-associated acute lung injury through activating akt signaling pathway

Inhibition of Nuclear Factor of Activated T Cells (NFAT) C3 Activation Attenuates Acute Lung Injury and Pulmonary Edema in Murine Models of Sepsis.

Inhibition of Sphingosine Kinase 1 Attenuates Sepsis-induced Microvascular Leakage <i>via</i> Inhibiting Macrophage NLRP3 Inflammasome Activation in Mice